精选80CNBC 财经（RSS）股市
美国医保首次覆盖肥胖症药物，诺和诺德与礼来受益
Medicare will start covering obesity drugs for the first time. Here's what patients should know
推荐理由
这是美国医保政策的重大变化，直接影响诺和诺德和礼来等制药巨头的市场前景，值得投资者关注相关标的的长期增长潜力。
The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.
更进一步：量化金融体系
看懂新闻只是起点——沿量化金融路径，把它变成能交付的工程能力